Belinostat

• Description :

  Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  318.35

• Molecular Formula :

  C15H14N2O4S

• Notes :

  Research use only, not for human use.

• Receptor :

  HDAC

• CAS Number :

  414864-00-9